A study of the under-reported adverse effects of sore lips led one consultant oncologist to concoct a lip salve made from natural oils, which is now being tested in a clinical trial. Medscape Medical News
More evidence to support the first-line use of erlotinib in nonsmall-cell lung cancer (NSCLC) testing positive for EGFR mutations. br / iMedscape Medical News/i
This oral targeted agent offers a new option for an orphan disease that has been treated for decades with aggressive intravenous chemotherapy. Medscape Medical News
Introducing early palliative care soon after diagnosis reduced use of chemotherapy and optimized transition to hospice, without affecting survival. Medscape Medical News